MedPath

Clinical trial study on rehabilitation of stroke with integrated traditional Chinese and western medicine based on multi-target nerve loop regulation Research Task One: Study on the Effect of Magnetic Regulation of Central and Peripheral Nerve Loop in Early Rehabilitation of Ischemic Stroke Research Task Two: Study&#32

Not Applicable
Recruiting
Conditions
stroke
Registration Number
ITMCTR2000003892
Lead Sponsor
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients diagnosed as ischemic stroke by clinical evaluation and comprehensive imaging examinations meet the diagnostic criteria for ischemic stroke;
2. Fugl-Meyer motor function score is confirmed as motor dysfunction;
3. Aged 18-70 years, no gender limit;
4. No cognitive impairment or communication impairment, with a score of 27 or more in the Simple Intelligence State Examination (MMSE);
5. The first onset, the course of illness is 2 days to January./ The first onset, the course of illness is from January to June. / Patients after nerve transfer.

Exclusion Criteria

1. Those who have serious systemic diseases such as cardiopulmonary disease and cannot tolerate rehabilitation treatment;
2. Patients with diagnosed psychosis, major depression (suicidal tendency) or epilepsy, and those with family history of psychosis or epilepsy;
3. Existence of serious systemic diseases such as diabetes and uremia;
4. Severe joint contracture;
5. Suffer from any cause of consciousness disorder;
6. According to safety guidelines, there are contraindications for transcranial direct current/magnetic stimulation (TMS/tDCS) and functional magnetic resonance (fMRI) examinations such as: metal foreign bodies in the body or other electronic devices implanted in the body;
7. Defects in hearing or vision may affect assessment and treatment;
8. Use drugs that change the excitability of the cerebral cortex (antiepileptic drugs, sedative hypnotic drugs, etc.).

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.